BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30604076)

  • 1. Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones.
    Della Penna A; Lange J; Hilbert J; Archid R; Königsrainer A; Quante M
    Obes Surg; 2019 Apr; 29(4):1216-1221. PubMed ID: 30604076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Incidence of Symptomatic Cholelithiasis After Bariatric Roux-En-Y Gastric Bypass and Previous Bariatric Surgery: a Single Center Experience.
    Sneineh MA; Harel L; Elnasasra A; Razin H; Rotmensh A; Moscovici S; Kais H; Shirin H
    Obes Surg; 2020 Mar; 30(3):846-850. PubMed ID: 31901127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
    Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
    Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
    BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant Cholecystectomy for Asymptomatic Gallstones in Bariatric Surgery-Safety Profile and Feasibility in a Large Tertiary Referral Bariatric Center.
    Allatif REA; Mannaerts GHH; Al Afari HST; Hammo AN; Al Blooshi MS; Bekdache OA; Alawadhi O; Isied SH; Hamid S; Shikora SA
    Obes Surg; 2022 Feb; 32(2):295-301. PubMed ID: 34791618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholelithiasis After Sleeve Gastrectomy and Effectiveness of Ursodeoxycholic Acid Treatment.
    Şen O; Türkçapar AG; Yerdel MA
    J Laparoendosc Adv Surg Tech A; 2020 Nov; 30(11):1150-1152. PubMed ID: 32228343
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
    Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
    Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of gallstone disease prior to and after metabolic surgery: a single-center observational study.
    Dirnberger AS; Schneider R; Slawik M; Linke K; Kraljević M; Wölnerhanssen B; Peterli R
    Surg Obes Relat Dis; 2022 Feb; 18(2):182-188. PubMed ID: 34764040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).
    Haal S; Guman MSS; de Brauw LM; van Veen RN; Schouten R; Fockens P; Gerdes VEA; Dijkgraaf MGW; Voermans RP
    Trials; 2020 Jul; 21(1):676. PubMed ID: 32703246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?
    Swartz DE; Felix EL
    Surg Obes Relat Dis; 2005; 1(6):555-60. PubMed ID: 16925290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding.
    Moon RC; Teixeira AF; DuCoin C; Varnadore S; Jawad MA
    Surg Obes Relat Dis; 2014; 10(1):64-8. PubMed ID: 23932005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta-analysis.
    Ying J; Dai S; Fu R; Hong J; Dai C; Jin Q
    Obesity (Silver Spring); 2022 Jun; 30(6):1170-1180. PubMed ID: 35475596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis.
    Magouliotis DE; Tasiopoulou VS; Svokos AA; Svokos KA; Chatedaki C; Sioka E; Zacharoulis D
    Obes Surg; 2017 Nov; 27(11):3021-3030. PubMed ID: 28889240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective Study of the Conservative Management of Asymptomatic Preoperative and Postoperative Gallbladder Disease in Bariatric Surgery.
    Pineda O; Maydón HG; Amado M; Sepúlveda EM; Guilbert L; Espinosa O; Zerrweck C
    Obes Surg; 2017 Jan; 27(1):148-153. PubMed ID: 27324135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid for prevention of gallstone disease after laparoscopic sleeve gastrectomy: an Atlantic Canada perspective.
    Hossain I; Brodie J; O'Brien E; Tedman-Aucoin K; Lawlor D; Murphy R; Twells L; Pace D; Evans B; Ellsmere J
    Surg Endosc; 2023 Jul; 37(7):5236-5240. PubMed ID: 36952047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Gallstone Formation and Cholecystectomy 10 Years After Bariatric Surgery.
    Melmer A; Sturm W; Kuhnert B; Engl-Prosch J; Ress C; Tschoner A; Laimer M; Laimer E; Biebl M; Pratschke J; Tilg H; Ebenbichler C
    Obes Surg; 2015 Jul; 25(7):1171-6. PubMed ID: 25589017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Concomitant Cholecystectomy Necessary for Asymptomatic Cholelithiasis During Laparoscopic Sleeve Gastrectomy?
    Yardimci S; Coskun M; Demircioglu S; Erdim A; Cingi A
    Obes Surg; 2018 Feb; 28(2):469-473. PubMed ID: 28803397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How frequently and when do patients undergo cholecystectomy after bariatric surgery?
    Tsirline VB; Keilani ZM; El Djouzi S; Phillips RC; Kuwada TS; Gersin K; Simms C; Stefanidis D
    Surg Obes Relat Dis; 2014; 10(2):313-21. PubMed ID: 24462305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.
    Abdallah E; Emile SH; Elfeki H; Fikry M; Abdelshafy M; Elshobaky A; Elgendy H; Thabet W; Youssef M; Elghadban H; Lotfy A
    Surg Today; 2017 Jul; 47(7):844-850. PubMed ID: 27837275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Factors of Cholelithiasis After Prophylactic Administration of Ursodeoxycholic Acid Following Laparoscopic Bariatric Surgery: Tehran Obesity Treatment Study.
    Barzin M; Andalib A; Khalaj A; Mahdavi M; Valizadeh M; Mousapour P; Hosseinpanah F
    Obes Surg; 2022 Feb; 32(2):311-317. PubMed ID: 34816356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.